Essential tremor - assessment of tremor accelerometric parameters' symmetry and the relationship between hand dominance and severity of tremor.

Neurol Neurochir Pol

Katedra i Klinika Neurologii Śląskiego Uniwersytetu Medycznego w Katowicach, Wydział Lekarski z Oddziałem Lekarsko-Dentystycznym w Zabrzu, ul. 3 Maja 13/15, 41-800 Zabrze.

Published: July 2011

Background And Purpose: Essential tremor (ET) is likely the most common movement disorder. The aim of the study was to carry out spectral analysis of the essential tremor recorded by an accelerometer and assess the symmetry of tremor parameters between the two hands.

Material And Methods: We examined 39 patients with ET diagnosed clinically using the criteria of the Movement Disorder Society. The control group consisted of 52 healthy persons. A biaxial accelerometer mounted at the dorsal side of the hand was used. Spectral analysis was performed. Tremor intensity, frequency of spectral peaks, centre frequency, standard deviation of the centre frequency, and harmonic index were measured. The side-to-side symmetry of these parameters was analysed. The relationship of hand dominance and severity of tremor was also analysed.

Results: There was significant side-to-side asymmetry of intensity in ET. The intensity in the more affected hand was over two times higher than that in the less affected one. The tremor was more severe in the nondominant hand in 62% of patients. In spite of significant difference in tremor intensity between the two sides, tremor frequency was similar in both hands. The standard deviation of centre frequency was significantly lower and the harmonic index was significantly higher in the more trembling hand.

Conclusions: Accelerometric registration revealed that asymmetry of intensity and symmetry of frequency are characteristic features of ET. The remaining two coefficients reflecting the rhythmicity and regularity of tremor also differed considerably between the hands.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0028-3843(14)60022-0DOI Listing

Publication Analysis

Top Keywords

essential tremor
12
centre frequency
12
tremor
11
relationship hand
8
hand dominance
8
dominance severity
8
severity tremor
8
movement disorder
8
spectral analysis
8
tremor intensity
8

Similar Publications

Advancing Parkinson's diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples.

Mol Cell Biochem

January 2025

Neurodegenerative Diseases Laboratory, Center for Biomedicine, Universidad Mayor, Avenida Alemania 0281, 4780000, Temuco, La Araucanía, Chile.

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by tremor, rigidity, and bradykinesia, beginning with early loss of dopaminergic neurons in the ventrolateral substantia nigra and advancing to broader neurodegeneration in the midbrain. The clinical heterogeneity of PD and the lack of specific diagnostic tests present significant challenges, highlighting the need for reliable biomarkers for early diagnosis. Alpha-synuclein (α-Syn), a protein aggregating into Lewy bodies and neurites in PD patients, has emerged as a key biomarker due to its central role in PD pathophysiology and potential to reflect pathological processes.

View Article and Find Full Text PDF

Susceptibility map-weighted MRI can distinguish tremor-dominant Parkinson's disease from essential tremor.

Sci Rep

January 2025

Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.

Distinguishing between Parkinson's disease (PD) and essential tremor (ET) can be challenging sometimes. Although positron emission tomography can confirm PD diagnosis, its application is limited by high cost and exposure to radioactive isotopes. Patients with PD exhibit loss of the dorsal nigral hyperintensity on brain magnetic resonance imaging (MRI).

View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) is a movement disorder linked to the degeneration of dopamine-producing neurons, and treatments like Levodopa (L-dopa) and Subthalamic Deep Brain Stimulation (STN-DBS) have distinct effects on brain activity that need further study.
  • In a study involving 21 PD patients on L-dopa and 11 patients with STN-DBS, researchers used Magnetoencephalogram (MEG) data to analyze how these treatments impacted brain state dynamics through a statistical method called the Time-delay embedded Hidden Markov Model (TDE-HMM).
  • Results showed that L-dopa enhanced motor state and beta wave activity in the brain, correlating
View Article and Find Full Text PDF

Predicting Post-Operative Side Effects in VIM MRgFUS Based on THalamus Optimized Multi Atlas Segmentation (THOMAS) on White-Matter-Nulled MRI: A Retrospective Study.

AJNR Am J Neuroradiol

December 2024

From the UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers (S.O., A.K., B.M.E., J.Y.), University of California, Los Angeles, Los Angeles, California

Background And Purpose: Precise and individualized targeting of the ventral intermediate thalamic nucleus for the MR-guided focused ultrasound is crucial for enhancing treatment efficacy and avoiding undesirable side effects. In this study, we tested the hypothesis that the spatial relationships between Thalamus Optimized Multi Atlas Segmentation derived segmentations and the post-focused ultrasound lesion can predict post-operative side effects in patients treated with MR-guided focused ultrasound.

Materials And Methods: We retrospectively analyzed 30 patients (essential tremor, n = 26; tremor-dominant Parkinson's disease, n = 4) who underwent unilateral ventral intermediate thalamic nucleus focused ultrasound treatment.

View Article and Find Full Text PDF

Correlation of the clinical rating scale for tremor with a global assessment.

Clin Neurol Neurosurg

December 2024

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Objective: The Fahn-Tolosa-Marín Clinical Rating Scale for Tremor (CRST) includes three parts (tremor severity, motor task performance, functional disability) and a separate global assessment of impairment completed by both the patient and examiner. Although the CRST is used to determine tremor severity and the efficacy of treatments for tremor, the instrument may not sufficiently capture the patient's perspective. The objective of this study was to determine the association of the CRST subpart and total scores with the global assessment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!